| Real-World Evidence Study for the Safety and Effectiveness of Ribociclib in Combination with Hormonal Therapy in Patients with HR+/HER2- Advanced or Metastatic Breast Cancer in the Middle East Region |
Ongoing |
Ribociclib |
4 |
CLEE011AIC |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| The Effect of Empagliflozin (SGLT2 Inhibitor) in Pulmonary Arterial Hypertension: A Single Arm Prospective Interventional Study |
Ongoing |
Empagliflozin |
2 |
2231281 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A multicenter real-world evidence study with retrospective chart review and cross-sectional survey to evaluate the satisfaction and benefits of long-term repeated BOTOX treatment for upper facial lines |
Ongoing |
Botox |
4 |
H24-500 |
Derma Clinic |
| Phase II, Prospective, Randomized, placebo-controlled, double-blind study.Evaluation of Phytochemical properties and Phytotherapeutic Potential of Boswellia carteri Birdw. in Psoriasis |
Ongoing |
boswellia carteri (Psorelia) |
2 |
E-23-7585 |
King Khalid University Hospital (Riyadh) |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH) |
Ongoing |
Seralutinib |
3 |
GB002-3101 |
King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh) |
| Long-term Follow-up of Patients with Spinal Muscular Atrophy Treated with OAV101 IT or OAV101 IV in Clinical Trials |
Ongoing |
OAV101 (formerly AVXS-101) |
3 |
COAV101A12308 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Phase III, Randomised, Double -Blind, Active-controlled Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in Participants with CKD and High Blood Pressure |
Ongoing |
Baxdrostat |
3 |
D6972C00003 |
King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Specialist Hospital (Dammam),King Khalid University Hospital (Riyadh),King Abdulaziz Medical City NG (Riyadh) |
| Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of brigimadlin (BI 907828) for treatment of patients with locally advanced / metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours |
Ongoing |
BI 907828/ brigimadlin |
2 |
1403-0011 |
King Abdulaziz Medical City NG (Riyadh) |
| A Phase 3, Open-label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Treatment of Anemia in Pediatric Participants with Chronic Kidney Disease |
Ongoing |
roxadustat |
3 |
1517-CL-1003 |
King Faisal Specialist Hospital and Research Center (Riyadh),King Fahad Specialist Hospital (Dammam) |
| Evaluating the efficacy and safety of Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine) in Newly Diagnosed Advanced Hodgkin Lymphoma Early Interim PET-Positive Patients; A Multi-Center, Open Label, Single Arm, Phase II, PET-Adaptive Study |
Rejected |
BRENTUXIMAB VEDOTIN |
3 |
RJ19/119/J |
King Abdulaziz Medical City NG (Riyadh) |
